IRVINE - Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX Cosmetic Day on Wednesday, November 18, 2020.

The event is dedicated to celebrating the iconic treatment that helped create the aesthetics industry and recognizing the loyal community of patients and healthcare providers who have helped make this brand what it is today. In addition, this is a day for both new and loyal BOTOX Cosmetic users to put themselves first with an exclusive one-day-only offer available while supplies last exclusively through AllSM, the new loyalty platform from Allergan Aesthetics.

BOTOX Cosmetic Day is a very special holiday for Allergan Aesthetics. The brand is dedicated to encouraging patients and providers to do something for themselves especially ahead of the holiday season.

'BOTOX Cosmetic Day is also all about our loyal healthcare providers. From partnering with them on product formulations and clinical trials, to patient education and treatment, our providers are at the core of everything that goes into our products,' says Carrie Strom, Senior Vice President, AbbVie, and President, Global Allergan Aesthetics. 'There are ten million people considering a facial injectable treatment in the next year, and BOTOX Cosmetic Day serves as an opportunity to connect these consumers with healthcare providers in their area.1 We are incredibly grateful for the knowledge and diligent work providers contribute to our brands and the entire aesthetic category. We encourage everyone to thank their providers, even if it is a virtual celebration this year.'

On November 18, consumers who are new or existing members of AllSM, Allergan Aesthetics' new loyalty program, can participate in the exclusive offer which will be announced at 9 am Pacific Time on BOTOX Cosmetic Day at www.BOTOXCosmeticDay.Alle.com.

'BOTOX Cosmetic Day is a testament to the impact this brand has had on the aesthetic community,' said Dr. Jean Carruthers, MD, FRCSC, FRC (Ophth). 'In the past three decades, I've personally been on the front lines of continued research for this molecule and have witnessed the exponential increase in interest in this treatment, both among patients and the medical community worldwide.2 With the largest scientific and medical bibliography, BOTOX Cosmetic is the most widely studied treatment of its kind.3 I will continue to rely on BOTOX Cosmetic in my practice for its safety, efficacy and predictable results when treating my patients. I am honored to stand with my peers in the medical community and friends at Allergan Aesthetics to celebrate the one and only BOTOX Cosmetic.'

BOTOX Cosmetic is the first and only neurotoxin FDA-approved to temporarily improve the appearance of moderate to severe forehead lines, crow's feet lines, and glabellar lines in adults, and physicians have relied on it for more than 18 years.4 Recognized by National Day Archives as an official holiday on the National Day Registry, BOTOX Cosmetic Day is held annually on the third Wednesday in November.

About Allergan Aesthetics

Allergan Aesthetics, an AbbVie company, develops, manufactures, and markets a portfolio of leading aesthetics brands and products. Their aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Their goal is to consistently provide customers worldwide with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Contact:

Liz Shea

Tel: (847) 935-2211

Email: Liz.Shea@AbbVie.com

(C) 2020 Electronic News Publishing, source ENP Newswire